Switzerland· 65673007

Entresto

A valsartan and sacubitril product containing sacubitrilum, valsartanum, registered in Switzerland and dispensed under Swissmedic category B, on the national reimbursement list. The same ATC class is registered in 15 of our 19 countries.

Reimbursed in Switzerland (BAG SL)Cat B (Swissmedic)ATC C09DX04

Checked against BAG Spezialitätenliste (Switzerland) on

Informational only — not a medical device.

SOURCE REGISTER · CHBAG Spezialitätenliste (Switzerland)normalisedEntrestoATCC09DX04REGISTER NO.65673007PACKS LISTED1CHECKEDSeptember 12, 2026

Where it is registered

Valsartan and sacubitril is registered in 15 of 19 countries.

Countries holding a registration under ATC C09DX04 (valsartan and sacubitril), each read from that country’s own register.

  • This record: Switzerland, from BAG Spezialitätenliste (Switzerland)
  • 9 of them publish a price we can compare per daily dose

Valsartan and sacubitril · ATC C09DX04

15 / 19 countries

  • Belgiumprice
  • Canada
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Italyprice
  • Japan
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

BAG Spezialitätenliste (Switzerland)
Active substance
sacubitrilum, valsartanum
Manufacturer
—
Country
Switzerland (CH)
ATC code
C09DX04
ATC class
Valsartan and sacubitril
Swissmedic category
B
Reimbursed
Yes
Source register
BAG Spezialitätenliste (Switzerland)
Last checked
September 12, 2026

Packs & prices · 1

1 priced
  • gtin
    7680656730075
    168 Stk
    CHF 358

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

8 interactions on record for valsartan and sacubitril.

Graded by severity as the source publishes them — 8 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Valsartan and sacubitril · interactions on record

8 records

  • 8 moderate

Most severe, free to view

  • NitisinoneA16AX04moderate
  • SimvastatinC10AA01moderate
  • RosuvastatinC10AA07moderate
  • Darunavir and cobicistatJ05AR14moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valsartan and sacubitril in 13 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valsartan and sacubitril products

Authorised across Europe · EMA

The same active substance is authorised in 31 EEA countries. Names it is sold under:

  • Austria · Sabivalsax, Sacubitril/Valsartan Devatis
  • Belgium · Sacubitril/Valsartan Eg, Sacubitril/Valsartan Hcs
  • Bulgaria · Атрилесто, Валкубит
  • Cyprus · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Tad
  • Czechia · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Polpharma
  • Germany · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Al
  • Denmark · Bitrisal, Lumivaxon
  • Estonia · Culbista, Sacubitril/Valsartan Accord
  • Spain · Bidcor, Sacubitrilo / Valsartán Cinfamed
  • Finland · Lumivaxon, Sacubitril/Valsartan Accord
  • France · Sacubitril / Valsartan Biogaran, Sacubitril/Valsartan Accord
  • United Kingdom (Northern Ireland) · Sacubitril/Valsartan, Sacubitril/Valsartan Stada
  • Greece · Bitrisal, Ensavalia
  • Croatia · Atrilesto, Culbista
  • Hungary · Sacubitril/Valsartan Gedeon Richter, Sacubitril/Valsartan Stada
  • Ireland · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Krka
  • Iceland · Entresto, Neparvis
  • Italy · Sacubitril E Valsartan Accord, Sacubitril E Valsartan Alter
  • Liechtenstein · Entresto, Neparvis
  • Lithuania · Culbista, Sacubitril/Valsartan Polpharma
  • Luxembourg · Sacubitril/Valsartan Eg
  • Latvia · Culbista, Sacubitril/Valsartan Gedeon Richter
  • Malta · Sacubitril/Valsartan Axunio, Sacubitril/Valsartan Clonmel
  • Netherlands · Atrilesto, Brazier
  • Norway · Entresto, Neparvis
  • Poland · Brazier, Culbista
  • Portugal · Bidcor, Neprilin
  • Romania · Sacubitril/Valsartan Dr. Reddy’s, Sacubitril/Valsartan Gedeon Richter
  • Sweden · Sacubitril/Valsartan Accord, Sacubitril/Valsartan Axunio
  • Slovenia · Sakubitril/Valsartan Galenika, Sakubitril/Valsartan Hcs
  • Slovakia · Sacubitril/Valsartan Gedeon Richter, Sacubitril/Valsartan Polpharma

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of BAG Spezialitätenliste (Switzerland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/d96e5cc8-528f-4744-bc3f-e0688494bda9
GET /v1/drugs/d96e5cc8-528f-4744-bc3f-e0688494bda9?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "unit": null,
  "strength": "sacubitrilum 48.6 mg + valsartanum 51.4 mg",
  "valid_from": "2024-03-01",
  "limitations": "[{\"description\":\"<b>Herzinsuffizienz mit reduzierter Ejektionsfraktion (HFrEF)</b><br>\\nIn geeigneter Kombination mit anderen Therapien für Herzinsuffizienz (z.B. Betablocker, Diuretika und Mineralkortikoidantagonisten) für die Behandlung erwachsener Patienten mit systolischer Herzinsuffizienz der NYHA Klasse II, III oder IV, deren linksventrikuläre Auswurffraktion (LVEF) vor Behandlung mit Entresto ≤ 40% beträgt und welche mit einer stabilen Dosis eines Angiotensin Converting Enzym (ACE)-Hemmers oder Angiotensin Rezeptor-Blockers (ARBs) vorbehandelt worden sind.<br>\\n<br>\",\"costApproval\":null,\"indication\":\"\",\"isNew\":false,\"limitationCode\":null,\"points\":null,\"priceModel\":null,\"title\":null,\"validFrom\":\"2024-03-01\",\"validTo\":null}]",
  "galenic_form": "Filmtabl 100 mg",
  "therapeutic_area": null,
  "sl_inclusion_date": "2015-11-01",
  "self_retention_pct": 10
}

See everything about valsartan and sacubitril.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.